相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy
Annemieke Aartsma-Rus et al.
NUCLEIC ACID THERAPEUTICS (2020)
Efficient Conjugation to Phosphorothioate Oligonucleotides by Cu-Catalyzed Huisgen 1,3-Dipolar Cycloaddition
Malgorzata Honcharenko et al.
BIOCONJUGATE CHEMISTRY (2019)
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
Wen Shen et al.
NATURE BIOTECHNOLOGY (2019)
Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins
Michael T. Migawa et al.
NUCLEIC ACIDS RESEARCH (2019)
Therapeutic Oligonucleotides: State of the Art
C. I. Edvard Smith et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications
Sebastien Benizri et al.
BIOCONJUGATE CHEMISTRY (2019)
Effective gene silencing activity of prodrug-type 2'-O-methyldithiomethyl siRNA compared with non-prodrug-type 2'-O-methyl siRNA
Junsuke Hayashi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2′-MOE-Modified Antisense Oligonucleotide
Padmakumar Narayanan et al.
TOXICOLOGICAL SCIENCES (2018)
Hydrogen peroxide-triggered gene silencing in mammalian cells through boronated antisense oligonucleotides
Shohei Mori et al.
CHEMICAL SCIENCE (2018)
The chemical evolution of oligonucleotide therapies of clinical utility
Anastasia Khvorova et al.
NATURE BIOTECHNOLOGY (2017)
Oligonucleotide Therapeutics - A New Class of Cholesterol-Lowering Drugs
Anastasia Khvorova
NEW ENGLAND JOURNAL OF MEDICINE (2017)
FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides
Annemieke Aartsma-Rus
NUCLEIC ACID THERAPEUTICS (2017)
The Effects of 2′-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials
Stanley T. Crooke et al.
NUCLEIC ACID THERAPEUTICS (2017)
Syntheses of prodrug-type phosphotriester oligonucleotides responsive to intracellular reducing environment for improvement of cell membrane permeability and nuclease resistance
Junsuke Hayashi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Therapeutic nucleic acids: current clinical status
Kannan Sridharan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Development of Antisense Drugs for Dyslipidemia
Tsuyoshi Yamamoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2016)
The case for eteplirsen: Paving the way for precision medicine
M. Carrie Miceli et al.
MOLECULAR GENETICS AND METABOLISM (2016)
New Momentum for the Field of Oligonucleotide Therapeutics
Annemieke Aartsma-Rus
MOLECULAR THERAPY (2016)
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
NUCLEIC ACIDS RESEARCH (2016)
Four Novel Splice-Switch Reporter Cell Lines: Distinct Impact of Oligonucleotide Chemistry and Delivery Vector on Biological Activity
Cristina S. J. Rocha et al.
NUCLEIC ACID THERAPEUTICS (2016)
Considerations for the Characterization and Interpretation of Results Related to Alternative Complement Activation in Monkeys Associated with Oligonucleotide-Based Therapeutics
Scott P. Henry et al.
NUCLEIC ACID THERAPEUTICS (2016)
Cellular uptake and intracellular trafficking of oligonucleotides
R. L. Juliano et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Delivery of oligonucleotides with lipid nanoparticles
Yuhua Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Delivery of therapeutic oligonucleotides with cell penetrating peptides
Prisca Boisguerin et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Optimized luciferase assay for cell-penetrating peptide-mediated delivery of short oligonucleotides
Henrik Helmfors et al.
ANALYTICAL BIOCHEMISTRY (2015)
Synthesis, binding, nuclease resistance and cellular uptake properties of 2′-O-acetalester-modified oligonucleotides containing cationic groups
Annabelle Biscans et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Nuclease resistant oligonucleotides with cell penetrating properties
Stefan Milton et al.
CHEMICAL COMMUNICATIONS (2015)
Oligonucleotide Therapies: The Past and the Present
Karin E. Lundin et al.
HUMAN GENE THERAPY (2015)
Knocking down disease: a progress report on siRNA therapeutics
Anders Wittrup et al.
NATURE REVIEWS GENETICS (2015)
Ca2+ enrichment in culture medium potentiates effect of oligonucleotides
Shin-ichiro Hori et al.
NUCLEIC ACIDS RESEARCH (2015)
Antisense Oligonucleotide Therapies: The Promise and the Challenges from a Toxicologic Pathologist's Perspective
Kendall S. Frazier
TOXICOLOGIC PATHOLOGY (2015)
Oligonucleotide delivery: a patent review (2010-2013)
Santiago Grijalvo et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Development of Therapeutic Splice-Switching Oligonucleotides
Petra Disterer et al.
HUMAN GENE THERAPY (2014)
Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model
Burcu Bestas et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications
Bryan R. Meade et al.
NATURE BIOTECHNOLOGY (2014)
Antisense oligonucleotides: modifications and clinical trials
Vivek K. Sharma et al.
MEDCHEMCOMM (2014)
Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
Fritz Eckstein
NUCLEIC ACID THERAPEUTICS (2014)
Synthesis and Stability of a 2′-O-[N-(Aminoethyl)carbamoyl]methyladenosine-Containing Dinucleotide
Stefan Milton et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2013)
Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9
Ekambar R. Kandimalla et al.
NUCLEIC ACIDS RESEARCH (2013)
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Jiehua Zhou et al.
PHARMACEUTICALS (2013)
Designing Chemically Modified Oligonucleotides for Targeted Gene Silencing
Glen F. Deleavey et al.
CHEMISTRY & BIOLOGY (2012)
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Ryszard Kole et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Antisense 2′-Deoxy, 2′-Fluoroarabino Nucleic Acid (2′F-ANA) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids
Naira Souleimanian et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Special delivery: targeted therapy with small RNAs
D. Peer et al.
GENE THERAPY (2011)
An activated triple bond linker enables 'click' attachment of peptides to oligonucleotides on solid support
Malgorzata Wenska et al.
NUCLEIC ACIDS RESEARCH (2011)
Genetic therapies for RNA mis-splicing diseases
Suzan M. Hammond et al.
TRENDS IN GENETICS (2011)
Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
C. A. Stein et al.
NUCLEIC ACIDS RESEARCH (2010)
Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity
Ines Neundorf et al.
PHARMACEUTICALS (2009)
Comparing in vitro and in vivo activity of 2′-O-[2-(methylamino)-2-oxoethyl]- and 2′-O-methoxyethyl-modified antisense oligonucleotides
Thazha P. Prakash et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis of isotopically labeled P-site substrates for the ribosomal peptidyl transferase reaction
Minghong Zhong et al.
JOURNAL OF ORGANIC CHEMISTRY (2008)
Chemical modifications to improve the cellular uptake of oligonucleotides
Francoise Debart et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Cationic oligonucleotide-peptide conjugates with aggregating properties enter efficiently into cells while maintaining hybridization properties and enzymatic recognition
Andrew W. Fraley et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides
T Shiraishi et al.
CHEMISTRY & BIOLOGY (2005)
Oligonucleotides with 2 '-O-carboxymethyl group: synthesis and 2 '-conjugation via amide bond formation on solid phase
A Kachalova et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2004)
Uptake and quantification of intracellular concentration of lipophilic pro-oligonucleotides in HeLa cells
JC Bologna et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2002)
A novel enzymatic method for the production of purine-2′-deoxyribonucleosides
K Yokozeki et al.
JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC (2000)
Synthesis of antisense oligonucleotides: Replacement of 3H-1,2-benzodithiol-3-one 1,1-dioxide (Beaucage reagent) with phenylacetyl disulfide (PADS) as efficient sulfurization reagent: From bench to bulk manufacture of active pharmaceutical ingredient
ZS Cheruvallath et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2000)
分享论文
